Soteropoulos Paula 4
4 · uniQure N.V. · Filed Dec 15, 2022
Insider Transaction Report
Form 4
uniQure N.V.QURE
Soteropoulos Paula
Director
Transactions
- Sale
Ordinary Shares
2022-12-13$23.45/sh−3,000$70,350→ 16,382 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-12-13−3,000→ 8,000 totalExercise: $5.37From: 2018-01-27Exp: 2027-01-27→ Ordinary Shares (3,000 underlying) - Exercise/Conversion
Ordinary Shares
2022-12-13$5.37/sh+3,000$16,110→ 19,382 total - Exercise/Conversion
Ordinary Shares
2022-12-14+3,800→ 20,182 total - Sale
Ordinary Shares
2022-12-14$23.43/sh−3,800$89,034→ 16,382 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-12-14−3,800→ 0 totalExp: 2023-06-06→ Ordinary Shares (3,800 underlying)
Footnotes (3)
- [F1]The reported transactions were effected pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.
- [F2]The Stock Option exercise price was EUR 10.10 per share or $10.69, as converted, based on the exchange rate at on December 13, 2022 of EUR 1 to $1.058.
- [F3]The Stock Option was granted on June 6, 2013 and vested 25% after one year, with the remainder vesting in weekly installments over a two year period ending on June 10, 2016.